Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
United States Department of Veterans Affairs | 40 | 2024 | 941 | 2.370 |
Why?
|
HIV Infections | 72 | 2024 | 17589 | 1.890 |
Why?
|
Hepatitis C | 16 | 2021 | 1595 | 1.880 |
Why?
|
Hepatitis C, Chronic | 14 | 2021 | 1033 | 1.730 |
Why?
|
Medication Adherence | 17 | 2024 | 2192 | 1.580 |
Why?
|
Veterans | 29 | 2023 | 2672 | 1.530 |
Why?
|
Anti-HIV Agents | 20 | 2024 | 4576 | 1.100 |
Why?
|
Veterans Health | 10 | 2023 | 216 | 0.920 |
Why?
|
Self Care | 8 | 2013 | 801 | 0.900 |
Why?
|
Antiviral Agents | 11 | 2021 | 3069 | 0.870 |
Why?
|
HIV Seropositivity | 6 | 2016 | 967 | 0.780 |
Why?
|
Primary Health Care | 15 | 2024 | 4748 | 0.770 |
Why?
|
Drug Users | 3 | 2023 | 134 | 0.700 |
Why?
|
Patient Education as Topic | 9 | 2013 | 2339 | 0.650 |
Why?
|
Substance-Related Disorders | 10 | 2023 | 4429 | 0.640 |
Why?
|
Health Records, Personal | 3 | 2013 | 127 | 0.560 |
Why?
|
Hospitals, Veterans | 7 | 2017 | 395 | 0.560 |
Why?
|
Patient Compliance | 11 | 2014 | 2701 | 0.550 |
Why?
|
Vulnerable Populations | 2 | 2013 | 718 | 0.520 |
Why?
|
Attitude of Health Personnel | 6 | 2023 | 3925 | 0.490 |
Why?
|
Nausea | 1 | 2018 | 682 | 0.480 |
Why?
|
Telemedicine | 9 | 2024 | 3109 | 0.470 |
Why?
|
Vomiting | 1 | 2018 | 655 | 0.470 |
Why?
|
Patient Acceptance of Health Care | 6 | 2020 | 3233 | 0.450 |
Why?
|
AIDS Serodiagnosis | 3 | 2009 | 220 | 0.430 |
Why?
|
United States | 77 | 2024 | 73180 | 0.420 |
Why?
|
Social Stigma | 2 | 2016 | 788 | 0.410 |
Why?
|
Interviews as Topic | 14 | 2023 | 2742 | 0.410 |
Why?
|
Diarrhea | 3 | 2018 | 1319 | 0.410 |
Why?
|
Substance Abuse, Intravenous | 4 | 2023 | 530 | 0.380 |
Why?
|
Hypogonadism | 1 | 2018 | 805 | 0.380 |
Why?
|
Patient Care Team | 6 | 2021 | 2527 | 0.370 |
Why?
|
Antiretroviral Therapy, Highly Active | 8 | 2006 | 1903 | 0.370 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2012 | 197 | 0.370 |
Why?
|
Treatment Refusal | 3 | 2007 | 432 | 0.360 |
Why?
|
Counseling | 4 | 2022 | 1554 | 0.360 |
Why?
|
Patient Participation | 5 | 2007 | 1448 | 0.360 |
Why?
|
Testosterone | 2 | 2018 | 2494 | 0.340 |
Why?
|
Mass Screening | 11 | 2017 | 5455 | 0.340 |
Why?
|
Ethics, Research | 1 | 2011 | 178 | 0.340 |
Why?
|
Clinical Trials as Topic | 7 | 2011 | 8055 | 0.340 |
Why?
|
Delivery of Health Care | 15 | 2023 | 5375 | 0.330 |
Why?
|
Acquired Immunodeficiency Syndrome | 6 | 2019 | 2203 | 0.320 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2010 | 155 | 0.320 |
Why?
|
Multi-Institutional Systems | 1 | 2008 | 43 | 0.310 |
Why?
|
Reminder Systems | 6 | 2014 | 388 | 0.310 |
Why?
|
Mind-Body Therapies | 1 | 2012 | 294 | 0.300 |
Why?
|
Humans | 147 | 2024 | 768887 | 0.290 |
Why?
|
Spirituality | 3 | 2007 | 430 | 0.290 |
Why?
|
Health Services Research | 4 | 2014 | 1818 | 0.290 |
Why?
|
Qualitative Research | 10 | 2023 | 3143 | 0.290 |
Why?
|
Stereotyping | 1 | 2009 | 241 | 0.290 |
Why?
|
Anti-Retroviral Agents | 5 | 2023 | 1794 | 0.280 |
Why?
|
Middle Aged | 75 | 2023 | 223740 | 0.280 |
Why?
|
Self Stimulation | 1 | 2007 | 47 | 0.280 |
Why?
|
Depressive Disorder | 4 | 2016 | 3726 | 0.270 |
Why?
|
Health Personnel | 7 | 2023 | 3382 | 0.270 |
Why?
|
Alcohol-Related Disorders | 1 | 2009 | 243 | 0.270 |
Why?
|
Viral Load | 8 | 2024 | 3398 | 0.270 |
Why?
|
Education, Nursing, Continuing | 1 | 2006 | 69 | 0.270 |
Why?
|
Male | 86 | 2023 | 365249 | 0.260 |
Why?
|
Patient-Centered Care | 3 | 2024 | 1447 | 0.260 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2001 | 664 | 0.260 |
Why?
|
Telemetry | 1 | 2007 | 200 | 0.260 |
Why?
|
Delivery of Health Care, Integrated | 6 | 2023 | 954 | 0.260 |
Why?
|
Quality Assurance, Health Care | 4 | 2010 | 2181 | 0.250 |
Why?
|
Comprehension | 1 | 2011 | 639 | 0.250 |
Why?
|
Hepacivirus | 5 | 2018 | 1344 | 0.250 |
Why?
|
Adult | 66 | 2023 | 223818 | 0.250 |
Why?
|
Relaxation Therapy | 1 | 2006 | 181 | 0.240 |
Why?
|
Harm Reduction | 2 | 2023 | 143 | 0.240 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2007 | 580 | 0.240 |
Why?
|
Protease Inhibitors | 1 | 2008 | 752 | 0.240 |
Why?
|
Internet | 3 | 2014 | 3112 | 0.240 |
Why?
|
Informed Consent | 1 | 2011 | 1010 | 0.240 |
Why?
|
Female | 82 | 2023 | 397464 | 0.240 |
Why?
|
Stress, Psychological | 4 | 2012 | 4542 | 0.230 |
Why?
|
Tool Use Behavior | 1 | 2024 | 2 | 0.230 |
Why?
|
Residential Treatment | 2 | 2022 | 112 | 0.230 |
Why?
|
Ambulatory Care Facilities | 5 | 2021 | 941 | 0.230 |
Why?
|
Personnel, Hospital | 1 | 2006 | 285 | 0.230 |
Why?
|
Communication Barriers | 1 | 2007 | 419 | 0.230 |
Why?
|
Program Evaluation | 8 | 2024 | 2507 | 0.230 |
Why?
|
Monitoring, Ambulatory | 1 | 2007 | 358 | 0.220 |
Why?
|
Opioid-Related Disorders | 2 | 2016 | 2189 | 0.220 |
Why?
|
Health Promotion | 3 | 2013 | 2210 | 0.210 |
Why?
|
Depression | 7 | 2017 | 8240 | 0.210 |
Why?
|
Managed Care Programs | 1 | 2008 | 941 | 0.210 |
Why?
|
Disclosure | 3 | 2021 | 754 | 0.210 |
Why?
|
Focus Groups | 5 | 2019 | 1461 | 0.210 |
Why?
|
Cooperative Behavior | 4 | 2015 | 1515 | 0.200 |
Why?
|
Pilot Projects | 9 | 2014 | 8742 | 0.200 |
Why?
|
Therapeutic Human Experimentation | 1 | 2002 | 43 | 0.200 |
Why?
|
Antidepressive Agents | 2 | 2012 | 2914 | 0.200 |
Why?
|
Evidence-Based Practice | 3 | 2024 | 500 | 0.190 |
Why?
|
Patient Selection | 3 | 2020 | 4265 | 0.190 |
Why?
|
Continuity of Patient Care | 3 | 2018 | 1076 | 0.180 |
Why?
|
Quality of Life | 11 | 2013 | 13510 | 0.180 |
Why?
|
Quality Indicators, Health Care | 2 | 2008 | 1812 | 0.180 |
Why?
|
Biomedical Research | 3 | 2011 | 3463 | 0.180 |
Why?
|
Drug Evaluation | 1 | 2002 | 642 | 0.180 |
Why?
|
Organizational Innovation | 1 | 2023 | 540 | 0.170 |
Why?
|
Russia | 2 | 2019 | 386 | 0.170 |
Why?
|
Attitude | 2 | 2021 | 772 | 0.170 |
Why?
|
Critical Pathways | 2 | 2017 | 476 | 0.170 |
Why?
|
Headache | 3 | 2002 | 1263 | 0.160 |
Why?
|
Intention | 1 | 2021 | 348 | 0.160 |
Why?
|
Program Development | 3 | 2021 | 1300 | 0.150 |
Why?
|
Mental Disorders | 4 | 2015 | 6879 | 0.150 |
Why?
|
Anthropology, Cultural | 2 | 2018 | 103 | 0.150 |
Why?
|
Directive Counseling | 2 | 2010 | 171 | 0.150 |
Why?
|
Physician-Patient Relations | 4 | 2018 | 3269 | 0.150 |
Why?
|
Burnout, Professional | 1 | 2006 | 711 | 0.140 |
Why?
|
Aged | 35 | 2021 | 171790 | 0.140 |
Why?
|
Health Education | 2 | 2007 | 1059 | 0.140 |
Why?
|
Referral and Consultation | 3 | 2020 | 3626 | 0.140 |
Why?
|
California | 4 | 2009 | 1443 | 0.140 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2007 | 1898 | 0.140 |
Why?
|
Adaptation, Psychological | 3 | 2006 | 2667 | 0.140 |
Why?
|
Patient Satisfaction | 6 | 2021 | 3489 | 0.140 |
Why?
|
Mental Health Services | 2 | 2023 | 1732 | 0.140 |
Why?
|
Physician Assistants | 1 | 2019 | 190 | 0.140 |
Why?
|
Drug Utilization | 3 | 2017 | 1191 | 0.130 |
Why?
|
Medication Reconciliation | 1 | 2018 | 153 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2019 | 4053 | 0.130 |
Why?
|
New England | 1 | 2019 | 1058 | 0.130 |
Why?
|
Nurse Practitioners | 1 | 2019 | 271 | 0.130 |
Why?
|
Social Environment | 1 | 2021 | 1016 | 0.130 |
Why?
|
Morals | 1 | 2018 | 288 | 0.120 |
Why?
|
Healthcare Disparities | 3 | 2018 | 3421 | 0.120 |
Why?
|
Government Programs | 1 | 2017 | 278 | 0.120 |
Why?
|
Severity of Illness Index | 9 | 2018 | 15955 | 0.120 |
Why?
|
Telephone | 2 | 2023 | 630 | 0.120 |
Why?
|
Treatment Outcome | 18 | 2020 | 65485 | 0.120 |
Why?
|
Logistic Models | 12 | 2020 | 13317 | 0.120 |
Why?
|
Religion and Psychology | 2 | 2006 | 180 | 0.120 |
Why?
|
Comorbidity | 6 | 2021 | 10591 | 0.110 |
Why?
|
Personal Autonomy | 1 | 2016 | 315 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2019 | 1195 | 0.110 |
Why?
|
Guideline Adherence | 3 | 2019 | 2240 | 0.110 |
Why?
|
Communication | 5 | 2023 | 3908 | 0.110 |
Why?
|
Fatigue | 1 | 2001 | 1557 | 0.110 |
Why?
|
Appointments and Schedules | 2 | 2014 | 443 | 0.110 |
Why?
|
Professional-Patient Relations | 2 | 2016 | 725 | 0.110 |
Why?
|
Health Care Surveys | 4 | 2017 | 2437 | 0.110 |
Why?
|
Child Behavior | 1 | 2019 | 865 | 0.110 |
Why?
|
Community-Based Participatory Research | 1 | 2014 | 223 | 0.100 |
Why?
|
Vaccination | 2 | 2023 | 3436 | 0.100 |
Why?
|
Patient Care | 1 | 2018 | 629 | 0.100 |
Why?
|
China | 2 | 2016 | 2395 | 0.100 |
Why?
|
Perception | 1 | 2019 | 1209 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 625 | 0.100 |
Why?
|
Motivation | 3 | 2020 | 2030 | 0.100 |
Why?
|
Cohort Studies | 14 | 2023 | 41800 | 0.090 |
Why?
|
Quality of Health Care | 2 | 2021 | 4338 | 0.090 |
Why?
|
Family Practice | 1 | 1994 | 509 | 0.090 |
Why?
|
Urban Health Services | 1 | 2012 | 177 | 0.090 |
Why?
|
Dermatology | 1 | 2021 | 905 | 0.090 |
Why?
|
Nurse Administrators | 1 | 2011 | 45 | 0.090 |
Why?
|
Truth Disclosure | 1 | 2014 | 433 | 0.090 |
Why?
|
Health Priorities | 1 | 2013 | 380 | 0.090 |
Why?
|
Gastroenterology | 1 | 2017 | 593 | 0.090 |
Why?
|
Health Services Accessibility | 4 | 2002 | 5520 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1190 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10397 | 0.090 |
Why?
|
RNA, Viral | 4 | 2009 | 2871 | 0.090 |
Why?
|
HIV | 2 | 2009 | 1596 | 0.090 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1962 | 0.090 |
Why?
|
Research Personnel | 1 | 2014 | 590 | 0.080 |
Why?
|
Health Behavior | 4 | 2016 | 2649 | 0.080 |
Why?
|
HIV Seroprevalence | 1 | 2009 | 89 | 0.080 |
Why?
|
General Practitioners | 1 | 2010 | 103 | 0.080 |
Why?
|
Practice Guidelines as Topic | 7 | 2018 | 7460 | 0.080 |
Why?
|
Optic Neuritis | 1 | 2011 | 175 | 0.080 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26384 | 0.080 |
Why?
|
Risk Factors | 14 | 2019 | 74971 | 0.080 |
Why?
|
Preventive Health Services | 1 | 1994 | 568 | 0.080 |
Why?
|
Organizational Policy | 1 | 2011 | 434 | 0.080 |
Why?
|
Analysis of Variance | 4 | 2014 | 6242 | 0.080 |
Why?
|
Self Efficacy | 1 | 2013 | 643 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2183 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2537 | 0.080 |
Why?
|
Medicine | 2 | 2014 | 947 | 0.080 |
Why?
|
Pharmacists | 1 | 2011 | 261 | 0.080 |
Why?
|
Medical Errors | 1 | 2016 | 1262 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2017 | 1673 | 0.070 |
Why?
|
Optic Nerve | 1 | 2011 | 571 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2015 | 2783 | 0.070 |
Why?
|
Policy Making | 1 | 2011 | 546 | 0.070 |
Why?
|
Retrospective Studies | 15 | 2024 | 81892 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 495 | 0.070 |
Why?
|
Consumer Health Information | 1 | 2010 | 215 | 0.070 |
Why?
|
Medical Order Entry Systems | 1 | 2012 | 523 | 0.070 |
Why?
|
Prisoners | 1 | 2010 | 316 | 0.070 |
Why?
|
Nursing Education Research | 1 | 2006 | 11 | 0.070 |
Why?
|
South Africa | 2 | 2023 | 1872 | 0.070 |
Why?
|
Fosinopril | 1 | 2006 | 7 | 0.070 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2008 | 239 | 0.070 |
Why?
|
Odds Ratio | 4 | 2011 | 9682 | 0.070 |
Why?
|
Existentialism | 1 | 2006 | 38 | 0.070 |
Why?
|
HIV-1 | 4 | 2010 | 6963 | 0.070 |
Why?
|
Uganda | 2 | 2022 | 1354 | 0.070 |
Why?
|
Cultural Characteristics | 1 | 2007 | 250 | 0.070 |
Why?
|
Adolescent | 17 | 2019 | 89247 | 0.070 |
Why?
|
Grief | 1 | 2008 | 256 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2016 | 39394 | 0.060 |
Why?
|
Primary Prevention | 1 | 2013 | 1187 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2019 | 5323 | 0.060 |
Why?
|
Pandemics | 5 | 2024 | 8745 | 0.060 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 138 | 0.060 |
Why?
|
Socioeconomic Factors | 7 | 2014 | 7860 | 0.060 |
Why?
|
Cell Division | 1 | 2013 | 4478 | 0.060 |
Why?
|
Health Policy | 2 | 2014 | 2700 | 0.060 |
Why?
|
Psychiatry | 2 | 2023 | 1716 | 0.060 |
Why?
|
Wrist | 1 | 2007 | 231 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8765 | 0.060 |
Why?
|
Mental Health | 3 | 2022 | 3275 | 0.060 |
Why?
|
Societies, Medical | 1 | 2017 | 3967 | 0.060 |
Why?
|
Cost-Benefit Analysis | 4 | 2016 | 5544 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3629 | 0.060 |
Why?
|
Organizational Culture | 1 | 2008 | 512 | 0.060 |
Why?
|
Multivariate Analysis | 6 | 2007 | 12093 | 0.060 |
Why?
|
Delphi Technique | 1 | 2008 | 890 | 0.060 |
Why?
|
Postpartum Period | 2 | 2022 | 1198 | 0.060 |
Why?
|
Self Report | 2 | 2017 | 3773 | 0.060 |
Why?
|
Benzazepines | 1 | 2006 | 309 | 0.060 |
Why?
|
Health Status | 3 | 2014 | 4095 | 0.060 |
Why?
|
Vision Disorders | 1 | 2011 | 1093 | 0.060 |
Why?
|
Prospective Studies | 7 | 2020 | 54950 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7956 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 4 | 2019 | 2598 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2431 | 0.050 |
Why?
|
Evaluation Studies as Topic | 2 | 2019 | 1629 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1541 | 0.050 |
Why?
|
Meditation | 1 | 2006 | 257 | 0.050 |
Why?
|
Drug Therapy, Combination | 4 | 2013 | 6320 | 0.050 |
Why?
|
Life Expectancy | 2 | 2013 | 1249 | 0.050 |
Why?
|
Psychology | 1 | 2004 | 354 | 0.050 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14795 | 0.050 |
Why?
|
Pneumocystis Infections | 1 | 2001 | 10 | 0.050 |
Why?
|
Narcotic Antagonists | 1 | 2007 | 591 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4926 | 0.050 |
Why?
|
Pneumocystis | 1 | 2001 | 55 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4642 | 0.050 |
Why?
|
Mycobacterium avium Complex | 1 | 2001 | 66 | 0.050 |
Why?
|
Time Factors | 5 | 2020 | 40266 | 0.050 |
Why?
|
Cough | 2 | 2004 | 598 | 0.050 |
Why?
|
Body Image | 1 | 2006 | 646 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2680 | 0.050 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2001 | 82 | 0.050 |
Why?
|
Leukoplakia | 1 | 2000 | 18 | 0.050 |
Why?
|
Videoconferencing | 1 | 2023 | 209 | 0.050 |
Why?
|
Poverty | 1 | 2013 | 2720 | 0.050 |
Why?
|
Young Adult | 7 | 2019 | 60110 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2011 | 2426 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2017 | 15471 | 0.040 |
Why?
|
Retina | 1 | 2011 | 2661 | 0.040 |
Why?
|
Chronic Disease | 4 | 2010 | 9384 | 0.040 |
Why?
|
Prejudice | 2 | 2018 | 574 | 0.040 |
Why?
|
Biopsy | 1 | 2012 | 6805 | 0.040 |
Why?
|
Case Management | 2 | 2015 | 276 | 0.040 |
Why?
|
Research Subjects | 1 | 2002 | 249 | 0.040 |
Why?
|
Occupational Health | 1 | 2006 | 812 | 0.040 |
Why?
|
Insurance, Health | 3 | 2012 | 2518 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1796 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1514 | 0.040 |
Why?
|
Self-Assessment | 1 | 2001 | 400 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2024 | 732 | 0.040 |
Why?
|
Complementary Therapies | 1 | 2003 | 487 | 0.040 |
Why?
|
Buprenorphine | 1 | 2007 | 667 | 0.040 |
Why?
|
Pregnancy | 3 | 2022 | 30175 | 0.040 |
Why?
|
Protective Devices | 1 | 2019 | 72 | 0.040 |
Why?
|
Total Quality Management | 1 | 2000 | 265 | 0.040 |
Why?
|
Health Planning | 1 | 2000 | 233 | 0.040 |
Why?
|
Physicians | 1 | 2016 | 4607 | 0.040 |
Why?
|
Feedback | 1 | 2022 | 799 | 0.040 |
Why?
|
Vietnam | 1 | 2019 | 415 | 0.040 |
Why?
|
Databases, Factual | 4 | 2020 | 8095 | 0.040 |
Why?
|
Medical Records | 2 | 2019 | 1411 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 368 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3856 | 0.040 |
Why?
|
Fear | 1 | 2006 | 1494 | 0.040 |
Why?
|
Age Factors | 4 | 2019 | 18454 | 0.040 |
Why?
|
Survival Analysis | 4 | 2013 | 10115 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14751 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2011 | 59738 | 0.030 |
Why?
|
Attitude to Health | 2 | 2003 | 2025 | 0.030 |
Why?
|
Insurance Coverage | 3 | 2018 | 1946 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2026 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2021 | 393 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1327 | 0.030 |
Why?
|
Housing | 1 | 2021 | 680 | 0.030 |
Why?
|
Patients | 1 | 2023 | 908 | 0.030 |
Why?
|
Liver | 1 | 2012 | 7579 | 0.030 |
Why?
|
Leadership | 2 | 2016 | 1396 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2011 | 3250 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2012 | 3438 | 0.030 |
Why?
|
Needs Assessment | 1 | 2002 | 1142 | 0.030 |
Why?
|
Pregnant Women | 1 | 2020 | 571 | 0.030 |
Why?
|
Treatment Failure | 1 | 2022 | 2663 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2006 | 3335 | 0.030 |
Why?
|
Melanoma | 1 | 2013 | 5709 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2011 | 20244 | 0.030 |
Why?
|
Weight Loss | 2 | 2004 | 2720 | 0.030 |
Why?
|
Advance Care Planning | 1 | 2001 | 698 | 0.030 |
Why?
|
Transcription Factors | 1 | 2013 | 12174 | 0.030 |
Why?
|
Mass Media | 1 | 2016 | 303 | 0.030 |
Why?
|
Homosexuality | 1 | 1994 | 269 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2000 | 1014 | 0.030 |
Why?
|
Medical Records Systems, Computerized | 2 | 2010 | 1196 | 0.030 |
Why?
|
Workplace | 1 | 2019 | 873 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3629 | 0.030 |
Why?
|
Regression Analysis | 4 | 2005 | 6346 | 0.030 |
Why?
|
Self Administration | 1 | 2013 | 388 | 0.030 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1994 | 242 | 0.020 |
Why?
|
Brain Diseases | 1 | 2001 | 1558 | 0.020 |
Why?
|
Health Surveys | 1 | 2001 | 4055 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2433 | 0.020 |
Why?
|
Proline | 1 | 2013 | 455 | 0.020 |
Why?
|
Ribavirin | 1 | 2013 | 395 | 0.020 |
Why?
|
Social Marketing | 1 | 2010 | 52 | 0.020 |
Why?
|
Professional-Family Relations | 1 | 2014 | 501 | 0.020 |
Why?
|
Population Surveillance | 1 | 2000 | 2597 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1994 | 1609 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2012 | 606 | 0.020 |
Why?
|
New York City | 1 | 2012 | 737 | 0.020 |
Why?
|
Interferons | 1 | 2013 | 720 | 0.020 |
Why?
|
Rural Population | 1 | 2020 | 2322 | 0.020 |
Why?
|
Terminal Care | 1 | 2001 | 1772 | 0.020 |
Why?
|
Attitude to Computers | 1 | 2010 | 196 | 0.020 |
Why?
|
Social Support | 1 | 1999 | 2193 | 0.020 |
Why?
|
Hepatitis C Antibodies | 1 | 2009 | 151 | 0.020 |
Why?
|
Laboratories, Hospital | 1 | 2010 | 192 | 0.020 |
Why?
|
Nurse-Patient Relations | 1 | 2008 | 101 | 0.020 |
Why?
|
Oligopeptides | 1 | 2013 | 1194 | 0.020 |
Why?
|
Urban Health | 1 | 2010 | 535 | 0.020 |
Why?
|
Child | 2 | 2019 | 80969 | 0.020 |
Why?
|
Models, Educational | 1 | 2010 | 375 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2007 | 60 | 0.020 |
Why?
|
Education | 1 | 2010 | 533 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21545 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2010 | 810 | 0.020 |
Why?
|
Oncogenes | 1 | 2013 | 1236 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.020 |
Why?
|
Caregivers | 1 | 2019 | 2308 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3631 | 0.020 |
Why?
|
Models, Biological | 1 | 2002 | 9499 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1886 | 0.020 |
Why?
|
Hypertension | 1 | 2006 | 8615 | 0.020 |
Why?
|
Risk Assessment | 3 | 2014 | 24330 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3903 | 0.020 |
Why?
|
Safety Management | 1 | 2011 | 765 | 0.020 |
Why?
|
Observer Variation | 1 | 2011 | 2623 | 0.020 |
Why?
|
Water | 1 | 2011 | 1421 | 0.010 |
Why?
|
Algorithms | 2 | 2017 | 14199 | 0.010 |
Why?
|
Prevalence | 3 | 2010 | 15875 | 0.010 |
Why?
|
Anger | 1 | 2006 | 405 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2483 | 0.010 |
Why?
|
Potassium | 1 | 2006 | 1319 | 0.010 |
Why?
|
Arizona | 1 | 2001 | 108 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2008 | 1406 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2008 | 1119 | 0.010 |
Why?
|
Visual Acuity | 1 | 2011 | 2714 | 0.010 |
Why?
|
Virus Replication | 1 | 2009 | 2458 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1994 | 4413 | 0.010 |
Why?
|
Sick Role | 1 | 2001 | 229 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2001 | 210 | 0.010 |
Why?
|
Self Concept | 1 | 2006 | 1046 | 0.010 |
Why?
|
Liver Diseases | 1 | 2009 | 1305 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2122 | 0.010 |
Why?
|
Advance Directives | 1 | 2001 | 249 | 0.010 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2001 | 395 | 0.010 |
Why?
|
Health Maintenance Organizations | 1 | 2002 | 657 | 0.010 |
Why?
|
Life Style | 1 | 2010 | 3931 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13048 | 0.010 |
Why?
|
Decision Making | 2 | 2003 | 3952 | 0.010 |
Why?
|
Nurses | 1 | 2008 | 2501 | 0.010 |
Why?
|
Attitude to Death | 1 | 2001 | 401 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5892 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7453 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2001 | 20776 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2003 | 2931 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2006 | 2228 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2007 | 2200 | 0.010 |
Why?
|
Medically Uninsured | 1 | 2002 | 841 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2013 | 4879 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10641 | 0.010 |
Why?
|
Demography | 1 | 2000 | 1643 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11684 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11934 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2000 | 1669 | 0.010 |
Why?
|
Benchmarking | 1 | 2000 | 1058 | 0.010 |
Why?
|
Homosexuality, Male | 1 | 2001 | 1344 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12873 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 30044 | 0.010 |
Why?
|
Forecasting | 1 | 2000 | 2946 | 0.010 |
Why?
|
Data Collection | 1 | 2000 | 3322 | 0.010 |
Why?
|
Health Care Costs | 1 | 2003 | 3270 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23652 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13677 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2000 | 4045 | 0.000 |
Why?
|
Mice | 1 | 2013 | 82074 | 0.000 |
Why?
|
Research Design | 1 | 2001 | 6213 | 0.000 |
Why?
|
Registries | 1 | 2000 | 8384 | 0.000 |
Why?
|
Medicare | 1 | 2002 | 6888 | 0.000 |
Why?
|
Animals | 1 | 2013 | 169408 | 0.000 |
Why?
|